Pharmacology, Toxicology and Pharmaceutical Science
Cystic Fibrosis
100%
Antibiotics
100%
Pseudomonas aeruginosa
100%
Tobramycin
100%
Ciprofloxacin
82%
Inhalation
76%
Nebulizer
76%
Antibiotic Agent
58%
Infection
47%
Placebo
41%
Colistin
35%
Ceftazidime
23%
Aztreonam Lysine
23%
Mortality
17%
Morbidity
17%
Adverse Event
17%
Azithromycin
17%
Blindness
5%
Randomized Controlled Trial
5%
Recurrent Disease
5%
Genetic Disorder
5%
Group Trial
5%
Intravenous Therapy
5%
Nursing and Health Professions
Cystic Fibrosis
100%
Tobramycin
100%
Ciprofloxacin
82%
Nebulizer
76%
Confidence Interval
70%
Antibiotic Agent
58%
Odds Ratio
52%
Infection
47%
Placebo
41%
Colistimethate
35%
Ceftazidime
23%
Adverse Event
17%
Time
17%
Mortality
17%
Morbidity
17%
Culture
17%
Azithromycin
17%
Inhalational Drug Administration
17%
Quality of Life
11%
Combination Therapy
11%
Isolation
11%
Standard
5%
Data Base
5%
Clinical Outcome
5%
Blindness
5%
Recurrent Disease
5%
Clinician
5%
Follow up
5%
Publication
5%
Child
5%
Missing Data
5%
Hazard Ratio
5%
Treatment Duration
5%
Genetic Disorder
5%
Intravenous Drug Administration
5%